Commit To Purchase Cellular Biomedicine Group At $22.50, Earn 31.5% Annualized Using Options
August 20, 2015 at 11:35 AM EDT
Investors considering a purchase of Cellular Biomedicine Group Inc (CBMG) stock, but cautious about paying the going market price of $22.86/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2016 put at the $22.50 strike, which has a bid at the time of this writing of $4.10..